Status:

COMPLETED

Information Processing at Sleep Onset and During Sleep in Patients With Insomnia

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Primary Insomnia

Eligibility:

All Genders

25-45 years

Brief Summary

Chronic insomnia is thought to occur as a result of hyperarousal. While there is a wealth of data to support this position, there is a lack of research to define how hyperarousal interferes with sleep...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Psychophysiologic Insomnia (PI)
  • These subjects will meet RDC criteria for Psychophysiologic insomnia. In addition, the complaint of disturbed sleep will have at least one of the following minimal characteristics:
  • \> 30 min. sleep-onset latency (SL) (Initial Insomnia)
  • \>2 awakenings per night (\>15 min. ea.) and/or wake after sleep-onset (WASO) of \> 30 min (Middle Insomnia)
  • Total Sleep Time (TST) will not exceed 6 hours \[unless the Sleep Efficiency (SE) quotient is \< 80%\] and the problem frequency must be \> 4 nights/week (Severe Insomnia) with a problem duration \> 6 months (Chronic Insomnia)B .
  • Inclusion Criteria for Good Sleeper Subjects
  • Report that they obtain enough sleep and that their sleep is restorative
  • Have a score of less than 10 on the Epworth Sleepiness Scale (ESS)50-52
  • Have a score of less than 15 on the Ford Insomnia Response to Stress Test (FIRST)53
  • Have a score of less than 7 on the Insomnia Severity Index (ISI)54
  • Report retrospectively and prospectively \< 15 minutes to fall asleep and "wake after sleep onset time" of \< 15 minutes and a total sleep time \> 6 hoursA
  • A These profiles will be evident at both intake (based on retrospective reports) and as an average from the two weeks of baseline diaries (based on prospective sampling).
  • Exclusion Criteria for All Subjects
  • • Unstable medical illness or acute or history of psychiatric illness (except GAD or MDD - Allowed provided that these have resolved and not recurred within 5 years) As ascertained with self report questionnaires, a clinical History, a physical exam and a clinical chemistry profile.
  • To assure that the insomnia is not secondary to these factors
  • Symptoms suggestive of sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • Polysomnographic data indicating sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • History of head injury with a sustained loss of consciousness To help assure that the EEG measures are unconfounded by brain damage
  • Evidence of active illicit substance use or fitting criteria for alcohol abuse or dependence To assure that the insomnia is not secondary to these factors
  • Use of CNS active medications including antidepressants and hypnotics (within 2 weeks or 5 half-lives) To help assure that the EEG measures are unconfounded by medication effects such as the "BZ artifact".
  • Inadequate language comprehension To assure the quality of self report data as all the measures are in English.
  • Pregnancy Excluded owing to the hormonal changes that occur with pregnancy
  • Left Handedness To control for EEG differences related to handedness
  • Nicotine Use To assure that the insomnia is not secondary to these factors
  • Caffeine use that exceeds 2 beverages per day or occurs past 5pm in the evening.
  • To assure that the insomnia is not secondary to these factors

Exclusion

    Key Trial Info

    Start Date :

    June 1 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 1 2010

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT00680199

    Start Date

    June 1 2008

    End Date

    July 1 2010

    Last Update

    October 28 2015

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Rochester Sleep and Neurophysiology Research Lab

    Rochester, New York, United States, 14642